Cyclerion Therapeutics
CYCN
CYCN
77 hedge funds and large institutions have $41.8M invested in Cyclerion Therapeutics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 18 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 24
82% less capital invested
Capital invested by funds: $237M → $41.8M (-$195M)
Holders
77
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.81M | |
| 2 | +$1.54M | |
| 3 | +$531K | |
| 4 |
D.E. Shaw & Co
New York
|
+$443K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$412K |
Top Sellers
| 1 | -$27M | |
| 2 | -$24.7M | |
| 3 | -$10.7M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.84M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.81M |